News

AddToAny

Google+ Facebook Twitter Twitter

“Poverty leaves mark on genes”

A new study challenges prevailing understandings of genes as immutable features of biology that are fixed at conception.

p8-11-news-dna-molecule-shutterstock-1022931832.jpg

Previous research has shown that socioeconomic status is a powerful determinant of human health and disease, and social inequality is a ubiquitous stressor for human populations globally.

In this study, researchers found evidence that poverty can become embedded across wide swaths of the genome.

They discovered lower socioeconomic status is associated with levels of DNA methylation (DNAm) – a key epigenetic mark that has the potential to shape gene expression – at more than 2,500 sites, across more than 1,500 genes.

They state that this means poverty leaves a mark on nearly 10% of the genes in the genome. Lead author Thomas McDade said experiences over the course of development can shape the genome’s function.  

 

Image credit | Shutterstock

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top